Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0265264 (
HOS
)
1,119
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report here in vivo gene transfer between cancer cells is associated with acquisition of high metastatic behavior. The 143B-GFP cell line with high metastatic potential and the MNNG/
HOS
-
RFP
cell line with low metastatic potential, both derived from the TE85 human osteosarcoma cell line, were either co-transplanted or transplanted alone in the tibia in nude mice. Upon mixed transplantation of the two differently labeled sublines, resulting metastatic colonies are single colored either red or green, thereby demonstrating their clonality and enabling facile color-coded quantification. When MNNG/
HOS
-
RFP
and 143B-GFP were co-transplanted in the tibia, the number of lung metastases of MNNG/
HOS
-
RFP
increased eight-fold compared to MNNG/
HOS
-
RFP
transplanted alone (P < 0.01). In contrast, no enhancement of MNNG/
HOS
-
RFP
metastases occurred when MNNG/
HOS
-
RFP
and 143B-GFP were transplanted separately in the right and left tibiae, respectively. This result suggests that the presence of 143B-GFP increased the metastatic potential of MNNG/
HOS
-
RFP
within the mixed tumor. We observed transfer of the Ki-ras gene from 143B-GFP to MNNG/
HOS
-
RFP
after they were co-implanted suggesting the Ki-ras played a role in increasing the metastatic potential of MNNG/
HOS
-
RFP
in the presence of 143B-GFP. These data suggest the possible role of in vivo gene transfer in enhancing the metastatic potential of cancer cells. The data also further demonstrated the power of color-coded imaging to visualize cancer-cell/cancer-cell interactions in vivo.
...
PMID:In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential. 1962 75